Showing results (431-440 of 484) with videos related to

Sort By:
Pageof 49
Respirology (Carlton, Vic.)|February 3, 2017
Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive SummaryClaus F Vogelmeier, Gerard J Criner, Fernando J Martinez, et al.
The European Respiratory Journal|January 24, 2015
Plasma pro-surfactant protein B and lung function decline in smokersJanice M Leung, John Mayo, Wan Tan, et al.
The New England Journal of Medicine|May 20, 2014
Simvastatin for the prevention of exacerbations in moderate-to-severe COPDGerard J Criner, John E Connett, Shawn D Aaron, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 19, 2021
Aryl hydrocarbon receptor deficiency causes the development of chronic obstructive pulmonary disease through the integration of multiple pathogenic mechanismsNecola Guerrina, Hussein Traboulsi, Angela Rico de Souza, et al.
The European Respiratory Journal|December 2, 2017
Surfactant protein D is a causal risk factor for COPD: results of Mendelian randomisationMa'en Obeidat, Xuan Li, Stephen Burgess, et al.
American Journal of Respiratory Cell and Molecular Biology|May 2, 2017
Integrative Genomics of Emphysema-Associated Genes Reveals Potential Disease BiomarkersMa'en Obeidat, Yunlong Nie, Nick Fishbane, et al.
The European Respiratory Journal|February 20, 2025
Transcriptomic profiling of the airway epithelium in COPD links airway eosinophilia to type 2 inflammation and corticosteroid responseClarus Leung, Hye Yun Park, Xuan Li, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 24, 2016
A Randomized Phase IIb Trial of myo-Inositol in Smokers with Bronchial DysplasiaStephen Lam, Sumithra J Mandrekar, Yaron Gesthalter, et al.
The European Respiratory Journal|June 15, 2019
IL-22 and its receptors are increased in human and experimental COPD and contribute to pathogenesisMalcolm R Starkey, Maximilian W Plank, Paolo Casolari, et al.
Pageof 49